Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Honeywell
HON
|
+$4B |
| 2 |
Visa
V
|
+$579M |
| 3 |
Amazon
AMZN
|
+$371M |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
+$369M |
| 5 |
UnitedHealth
UNH
|
+$352M |
Top Sells
| 1 |
Apple
AAPL
|
+$4.68B |
| 2 |
NVIDIA
NVDA
|
+$2.22B |
| 3 |
Microsoft
MSFT
|
+$2B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.98B |
| 5 |
Broadcom
AVGO
|
+$1.05B |
Sector Composition
| 1 | Technology | 31.54% |
| 2 | Consumer Discretionary | 12.6% |
| 3 | Financials | 12.44% |
| 4 | Industrials | 8.48% |
| 5 | Communication Services | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Global X US Infrastructure Development ETF
PAVE
$9.36B
| $121K | ﹤0.01% |
+3,000
| New | +$121K |
|
3627
Pyxis Oncology
PYXS
$116M
| $121K | ﹤0.01% |
77,013
+12,924
| +20% | +$20.3K |
|
3628
Tenaya Therapeutics
TNYA
$212M
| $121K | ﹤0.01% |
84,627
-184,837
| -69% | -$264K |
|
3629
Tootsie Roll Industries
TR
$2.88B
| $121K | ﹤0.01% |
3,860
-1,873
| -33% | -$58.7K |
|
|
SUNS
3630
Sunrise Realty Trust, Inc. Common Stock
SUNS
$148M
| $120K | ﹤0.01% |
8,484
+1,092
| +15% | +$15.4K |
|
3631
Ultrapar
UGP
$4.05B
| $119K | ﹤0.01% |
45,133
+36,700
| +435% | +$96.8K |
|
3632
Unilever
UL
$154B
| $119K | ﹤0.01% |
2,100
-99
| -5% | -$5.61K |
|
3633
XBiotech
XBIT
$85.4M
| $119K | ﹤0.01% |
30,004
+3,661
| +14% | +$14.5K |
|
3634
CureVac
CVAC
$1.21B
| $118K | ﹤0.01% |
34,836
+11,890
| +52% | +$40.3K |
|
3635
Lineage Cell Therapeutics
LCTX
$276M
| $118K | ﹤0.01% |
234,069
+22,769
| +11% | +$11.5K |
|
3636
VirTra
VTSI
$62.8M
| $117K | ﹤0.01% |
17,275
+2,247
| +15% | +$15.2K |
|
3637
Atomera
ATOM
$101M
| $116K | ﹤0.01% |
+10,000
| New | +$116K |
|
3638
inTEST
INTT
$88.6M
| $116K | ﹤0.01% |
13,473
| – | – |
|
3639
Seer Inc
SEER
$117M
| $116K | ﹤0.01% |
50,424
-14,002
| -22% | -$32.2K |
|
3640
InnovAge Holding
INNV
$560M
| $115K | ﹤0.01% |
29,099
+3,485
| +14% | +$13.8K |
|
3641
Invesco S&P 500 High Beta ETF
SPHB
$443M
| $115K | ﹤0.01% |
+1,300
| New | +$115K |
|
3642
Invesco Leisure and Entertainment ETF
PEJ
$469M
| $113K | ﹤0.01% |
2,160
| – | – |
|
3643
Ultralife
ULBI
$112M
| $113K | ﹤0.01% |
15,233
+1,838
| +14% | +$13.6K |
|
3644
AbCellera Biologics
ABCL
$1.28B
| $112K | ﹤0.01% |
38,351
+16,058
| +72% | +$46.9K |
|
3645
Bassett Furniture
BSET
$144M
| $112K | ﹤0.01% |
8,076
-2,048
| -20% | -$28.4K |
|
3646
AirSculpt Technologies
AIRS
$381M
| $109K | ﹤0.01% |
20,991
+1,891
| +10% | +$9.82K |
|
3647
ALX Oncology
ALXO
$62.7M
| $109K | ﹤0.01% |
65,122
+5,620
| +9% | +$9.41K |
|
|
VIGL
3648
DELISTED
Vigil Neuroscience
VIGL
| $109K | ﹤0.01% |
64,049
+19,436
| +44% | +$33.1K |
|
3649
Fractyl Health
GUTS
$70.1M
| $109K | ﹤0.01% |
52,926
+5,130
| +11% | +$10.6K |
|
|
BIOA
3650
BioAge Labs, Inc. Common Stock
BIOA
$173M
| $109K | ﹤0.01% |
18,791
+6,891
| +58% | +$40K |
|